BIM 📈 Biomerieux SA - Overview

BioMérieux SA is a leading developer and marketer of in vitro diagnostic solutions, primarily focusing on the diagnosis of infectious diseases. The company's product portfolio includes a wide range of solutions, such as the CHROMID RANGE, a chromogen culture media, and the RAPIDEC CARBA NP biochemical test for detecting carbapenemase-producing bacteria. Additionally, they offer air, surface, and water monitoring systems, which are essential for preventing the spread of infections in various settings. Their BACT/ALERT VIRTUO and BACT/ALERT 3D systems are designed for blood sample culture, while the BIOFIRE multiplex polymerase chain reaction (PCR) system and the BIOFIRE SPOTFIRE Lowplex PCR point-of-care system provide rapid and accurate diagnostic results.

The company's VITEK MS mass spectrometry system and VITEK 2 automated identification and antimicrobial susceptibility testing (AST) system are also notable products, as they enable healthcare professionals to quickly identify microorganisms and determine their susceptibility to various antibiotics. Furthermore, bioMérieux offers the API RANGE standardized ID strips, VITEK REVEAL Rapid AST system, and ETEST Gradient method on culture media, which are all designed to support the diagnosis and treatment of infectious diseases. Their BIOMERIEUX EPISEQ CS whole genome sequencing solution is used for epidemiologic monitoring, and the VIDAS B·R·A·H·M·S PCTTM is a specific marker of severe bacterial infections and sepsis.

BioMérieux also provides a range of software solutions, including the Biomérieux vision suite, which offers actionable information to support diagnosis and clinical decision-making. The company's culture media and associated instruments, as well as its ARGENE Monoplex PCR tests, are designed to meet the needs of various laboratories and healthcare settings. Their NUCLISENS ranges and EMAG system facilitate the automation of molecular biology laboratories and DNA and RNA extraction, while the ESTREAM automated preparation station enables the efficient processing of PCR tests. The GENE-UP and VERIFLOW ranges are used for the detection of microorganisms in the food industry, highlighting the company's commitment to ensuring food safety.

As a leading player in the biotechnology industry, bioMérieux SA serves a diverse range of customers, including clinical and hospital laboratories, physicians, blood banks, veterinarians, and industrial control laboratories. With a history dating back to 1963, the company has established itself as a trusted provider of innovative diagnostic solutions. Headquartered in Marcy-l'Étoile, France, bioMérieux SA is a subsidiary of Institut Mérieux SA and is listed on the stock exchange with the ISIN code FR0013280286, classified as a common stock under the GICS Sub Industry: Biotechnology.